Methamphetamine-induced impairment of memory and fleeting neuroinflammation: Profiling mRNA changes in mouse hippocampus following short-term and long-term exposure

Neuropharmacology. 2024 Dec 15:261:110175. doi: 10.1016/j.neuropharm.2024.110175. Epub 2024 Sep 30.

Abstract

Methamphetamine (METH) has been implicated in inducing memory impairment, but the precise mechanisms underlying this effect remain unclear. Current research often limits itself to singular models or focuses on individual gene or protein functions, which hampers a comprehensive understanding of the underlying mechanisms. In this study, we established three METH mouse exposure models, extracted hippocampal nuclei, and utilized RNA sequencing to analyze changes in mRNA expression profiles. Our results indicate that METH significantly impairs the learning and memory capabilities of mice. Additionally, we observed that METH-induced inflammatory responses occur in the early phase and do not further exacerbate with repeated injections. However, RNA sequencing revealed the persistent enrichment of inflammatory pathway molecules, which correlated with worsened behaviors. This suggests that although METH-induced neuroinflammation plays a critical role in learning and memory impairment, the continued enrichment of inflammatory pathway molecules is associated with behavioral outcomes. These findings provide crucial evidence for the potential application of immune intervention in METH-related disorders.

Keywords: Hippocampus; Immune tolerance; Memory deficits; Methamphetamine; Neuroinflammation.

MeSH terms

  • Animals
  • Central Nervous System Stimulants* / toxicity
  • Hippocampus* / drug effects
  • Hippocampus* / metabolism
  • Male
  • Memory Disorders* / chemically induced
  • Methamphetamine* / toxicity
  • Mice
  • Mice, Inbred C57BL*
  • Neuroinflammatory Diseases* / chemically induced
  • RNA, Messenger* / metabolism
  • Time Factors

Substances

  • Methamphetamine
  • RNA, Messenger
  • Central Nervous System Stimulants